Advances in Animal and Veterinary Sciences
Research Article
Adv. Anim. Vet. Sci. 9(10): 1684-1691
Figure 1
Edema diameter in arthritis, EPO and EVOO treated rats.
Figure 2
Total leucocytic count in arthritis, EPO and EVOO treated rats.
Figure 3
Platelets count in arthritis, EPO and EVOO treated rats.
Figure 4
Serum RF levels in arthritis, EPO and EVOO treated rats.
Figure 5
Serum TNF-α levels in arthritis, EPO and EVOO treated rats.
Figure 6
Serum IL-1β levels in arthritis, EPO and EVOO treated rats.
Figure 7
Serum IL-6 levels in arthritis, EPO and EVOO treated rats.
Figure 8
Ankles of rats 10 dpi by (H and E x 100). A: No histopathological changes in the control (normal) group; B: inflammatory cells (IC) infiltration and focal necrosis (FN) of articular cartilage in arthritis group; C: Few inflammatory cell infiltrations in the EPO-treated group; D: Few inflammatory cell infiltrations in EVOO-treated group.
Figure 9
Ankles of rat 21 dpi showing: by (H and E x 100). A: No histopathological changes in the control (normal) group; B: inflammatory cells (IC) infiltration and focal necrosis (FN) of articular cartilage in arthritis group; C: Few inflammatory cell infiltrations (H and E) in the EPO-treated group; D: Few inflammatory cell infiltrations (H and E) in EVOO-treated group.
Figure 10
Spleen of rat 10 dpi showing by (H and E x 100). A: No histopathological changes in the control (normal) group; B: lymphoblasts proliferation and mitotic figure in arthritis group; C: inflammatory cells infiltration in EPO treated group; D: inflammatory cells infiltration in EVOO treated group.
Figure 11
Spleen of rat 21 dpi by (H and E x 100) showing. A: No histopathological changes in the control (normal) group; B: lymphoblasts proliferation and mitotic figure in arthritis group; C: No histopathological changes in the EPO-treated group; D: No histopathological changes in the EVOO-treated group.